Name | Type | Posted | Actions |
|---|---|---|---|
Response to Questions Received from Industry.pdf | Aug 17, 2021 | ||
Attachment A.pdf | Aug 17, 2021 | ||
70RFP321REH000008 A0002.pdf | Aug 17, 2021 | ||
Amendment 0001 70RFP321REH000008.pdf | Aug 13, 2021 | ||
PWS Appendix III - 2011 National Agreement.pdf | Jul 29, 2021 | ||
PWS Appendix II - NPPD Drug Plan.pdf | Jul 29, 2021 | ||
PWS Appendix V - HHS Drug Free Workplace.pdf | Jul 29, 2021 | ||
PWS Appendix I - FPS Medical Standards.pdf | Jul 29, 2021 | ||
70RFP321REH000008.pdf | Jul 29, 2021 | ||
PWS Appendix IV - Duty Station Locations.pdf | Jul 29, 2021 |
Occupational Health & Medical Testing Services
Contact and place of performance
Fitzia L. Justice
Not specified
The Federal Protective Service is issuing a competitive request for proposal (RFP) using FAR Parts 12 and 13.5 procedures to solicit and award an IDIQ contract for the purpose of providing medical testing services for FPS employees. Services are required in all 50 states, Puerto Rico, US Virgin Islands, Mariana Islands and Guam. All quantities are not to exceed quantities. Five appendices are included with the solicitation.
The Office of Procurement Operations is issuing this combined synopsis and solicitation on behalf of the Federal Protective Service to secure occupational health and medical testing services. The requirement is being competed as a request for proposal under FAR Parts 12 and 13.5 procedures to award an Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The primary objective is to provide comprehensive medical testing for Federal Protective Service employees across all 50 states, Puerto Rico, the U.S. Virgin Islands, the Mariana Islands, and Guam.
Work under this contract falls under NAICS code 621511 for Medical Laboratories and PSC Q301 for Medical- Laboratory Testing. All established quantities within the solicitation are designated as not-to-exceed limits. The solicitation was originally published on July 29, 2021, and includes ten attachments such as a Performance Work Statement, a drug plan, and a national agreement.
The response deadline for solicitation 70RFP321REH000008 was August 17, 2021, with the notice last updated on February 14, 2022. Fitzia L. Justice is the designated point of contact for this requirement. Performance locations encompass the broad domestic and territorial footprint of the agency’s personnel.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.